# China NMPA Inspection - Jilin Huangzhihua Pharmaceutical Co., Ltd. - July 03, 2020

Source: https://www.globalkeysolutions.net/records/china_inspection/jilin-huangzhihua-pharmaceutical-co-ltd/13534102-d970-4dfd-8ae9-0e0849a4c296/
Source feed: China

> China NMPA unannounced inspection for Jilin Huangzhihua Pharmaceutical Co., Ltd. published July 03, 2020. The Jilin Provincial Drug Administration announced on July 3, 2020, its proposal to issue a Cosmetics Production License to Jilin Huangzhihua Pharmace

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Jilin Provincial Drug Administration's Notice on the Proposed Issuance of Cosmetic Production Licenses (No. 3 of 2020)
- Company Name: Jilin Huangzhihua Pharmaceutical Co., Ltd.
- Publication Date: 2020-07-03
- Product Type: cosmetics
- Summary: The Jilin Provincial Drug Administration announced on July 3, 2020, its proposal to issue a Cosmetics Production License to Jilin Huangzhihua Pharmaceutical Co., Ltd. This decision follows an on-site inspection and review conducted by the bureau, which found the company to be in compliance with the requirements outlined in the former State Food and Drug Administration's "Notice on Further Improving Current Work Related to Cosmetics Production Licensing." No violations or issues were identified during the review process; instead, the company successfully met the necessary criteria for licensing. Jilin Huangzhihua Pharmaceutical Co., Ltd., located in Tongyu County, Jilin Province, is slated to produce cream and lotion units for skin care and cleansing. The proposed license issuance, with Wang Daojun as the legal representative and company head, is currently under a 5-working-day public supervision period. This allows for public oversight and feedback regarding the proposed license.

Company: https://www.globalkeysolutions.net/companies/jilin-huangzhihua-pharmaceutical-co-ltd/2bf6cfa1-b07e-4f20-8f91-bcb154a9eb37/